| 2024-02-01 | Sale | Travere Therapeutics, Inc. TVTX | SVP, CHIEF ACCOUNTING OFFICER | 2,820 0.0036% | $8.53 | $24,058 | -15.81% | |
| 2024-01-23 | Sale | Travere Therapeutics, Inc. TVTX | SVP, CHIEF ACCOUNTING OFFICER | 910 0.0012% | $9.07 | $8,252 | -20.65% | |
| 2023-05-11 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 122 0.0002% | $16.12 | $1,967 | -46.33% | |
| 2023-05-10 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 436 0.0007% | $16.59 | $7,233 | -46.71% | |
| 2023-02-02 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 360 0.0005% | $22.42 | $8,071 | -32.06% | |
| 2023-02-01 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 1,671 0.0024% | $21.75 | $36,348 | -30.53% | |
| 2023-01-25 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 192 0.0003% | $21.63 | $4,153 | -27.69% | |
| 2023-01-24 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 905 0.0013% | $21.90 | $19,823 | -28.72% | |
| 2022-09-13 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 349 0.0006% | $28.00 | $9,772 | -23.36% | |
| 2022-05-10 | Sale | Travere Therapeutics, Inc. TVTX | SVP, Chief Accounting Officer | 436 0.0007% | $21.51 | $9,378 | -1.56% | |
| 2022-01-31 | Sale | Travere Therapeutics, Inc. TVTX | VP, Corp Controller and CAO | 798 0.0012% | $26.51 | $21,152 | -11.82% | |
| 2022-01-24 | Sale | Travere Therapeutics, Inc. TVTX | VP, Corp Controller and CAO | 934 0.0014% | $24.58 | $22,955 | -5.13% |